COPT Defense Properties (NYSE:CDP – Get Free Report) and Global Medical REIT (NYSE:XRN – Get Free Report) are both finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations and institutional ownership.
Dividends
COPT Defense Properties pays an annual dividend of $1.28 per share and has a dividend yield of 3.5%. Global Medical REIT pays an annual dividend of $1.92 per share and has a dividend yield of 5.1%. COPT Defense Properties pays out 92.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Global Medical REIT pays out -173.0% of its earnings in the form of a dividend. Global Medical REIT is clearly the better dividend stock, given its higher yield and lower payout ratio.
Volatility and Risk
COPT Defense Properties has a beta of 0.79, indicating that its stock price is 21% less volatile than the S&P 500. Comparatively, Global Medical REIT has a beta of 1.11, indicating that its stock price is 11% more volatile than the S&P 500.
Analyst Ratings
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| COPT Defense Properties | 0 | 3 | 5 | 0 | 2.63 |
| Global Medical REIT | 1 | 4 | 2 | 1 | 2.38 |
COPT Defense Properties presently has a consensus target price of $35.00, suggesting a potential downside of 3.99%. Global Medical REIT has a consensus target price of $40.00, suggesting a potential upside of 6.73%. Given Global Medical REIT’s higher possible upside, analysts clearly believe Global Medical REIT is more favorable than COPT Defense Properties.
Profitability
This table compares COPT Defense Properties and Global Medical REIT’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| COPT Defense Properties | 20.10% | 10.02% | 3.51% |
| Global Medical REIT | -6.06% | -2.19% | -0.73% |
Insider & Institutional Ownership
57.5% of Global Medical REIT shares are held by institutional investors. 1.7% of COPT Defense Properties shares are held by company insiders. Comparatively, 8.9% of Global Medical REIT shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Valuation and Earnings
This table compares COPT Defense Properties and Global Medical REIT”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| COPT Defense Properties | $763.92 million | 5.41 | $152.32 million | $1.38 | 26.42 |
| Global Medical REIT | $148.21 million | 3.35 | -$5.84 million | ($1.11) | -33.76 |
COPT Defense Properties has higher revenue and earnings than Global Medical REIT. Global Medical REIT is trading at a lower price-to-earnings ratio than COPT Defense Properties, indicating that it is currently the more affordable of the two stocks.
Summary
COPT Defense Properties beats Global Medical REIT on 10 of the 17 factors compared between the two stocks.
About COPT Defense Properties
COPT Defense Properties is a real estate investment trust. It acquires, develops, manages, sells, and leases out office properties and data centers. The firm operates through the following segments: Defense/Information Technology Locations, Regional Office, Wholesale Data Center, and Other. The company was founded on January 22,1988 and is headquartered in Columbia, MD.
About Global Medical REIT
Global Medical REIT Inc. (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
Receive News & Ratings for COPT Defense Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for COPT Defense Properties and related companies with MarketBeat.com's FREE daily email newsletter.
